ALNY

NASDAQ · Equity

Alnylam Pharmaceuticals Inc

US Healthcare Biotechnology

Latest week
29 May 2026
Close
301.980000
Fair value
266.763141
Expectation
Negative 44.15%
Weekly Close Trend Line Fair Value Activity Lines

Chart Summary

Key Points

Week Ending
29 May 2026
Latest Close
301.98
12-Week Change
-3.65%
Trend Signal
Inactive
Expectation
Negative 44.15%
Signal Weeks
0 of 12
Vs Trend Line
Below
Vs Fair Value
Above
Relative Strength
-34.49
Market Dynamics
-0.23

Over the latest 12 completed weeks ending 2026-05-29, ALNY fell 3.65%, moving from 313.41 to 301.98. The latest weekly close is below the Trend Line and above Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -34.49 and has softened across the 12-week window. Market Dynamics is -0.23 on the latest week. Expectation is negative at 44.15%.